TRIM16 and cardiomyopathy: Overall, our findings identify EBBP as a novel suppressor of ferroptosis in anthracycline‐induced cardiotoxicity via the PERK‐mediated ISR, thereby underscoring its therapeutic potential for preventing anthracycline‐induced cardiomyopathy.